Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-27,887
Closed -$2.11M 1393
2026
Q1
$2.11M Buy
27,887
+6,719
+32% +$505K 0.03% 446
2025
Q4
$1.58M Sell
21,168
-809
-4% -$59.1K 0.02% 512
2025
Q3
$1.48M Buy
21,977
+11,777
+115% +$782K 0.02% 524
2025
Q2
$663K Buy
10,200
+5,717
+128% +$343K 0.01% 730
2025
Q1
$275K Sell
4,483
-17,636
-80% -$1.17M 0.01% 971
2024
Q4
$1.59M Buy
22,119
+3,005
+16% +$235K 0.03% 475
2024
Q3
$1.49M Sell
19,114
-9,191
-32% -$735K 0.04% 465
2024
Q2
$2.1M Buy
28,305
+9,191
+48% +$689K 0.05% 377
2024
Q1
$1.49M Buy
19,114
+681
+4% +$50.7K 0.04% 466
2023
Q4
$1.32M Buy
18,433
+1,451
+9% +$101K 0.04% 468
2023
Q3
$1.18M Sell
16,982
-173
-1% -$13.1K 0.04% 439
2023
Q2
$1.39M Buy
17,155
+315
+2% +$25.7K 0.05% 378
2023
Q1
$1.36M Buy
16,840
+3,316
+25% +$267K 0.06% 366
2022
Q4
$1.01M Buy
13,524
+815
+6% +$58K 0.05% 371
2022
Q3
$820K Buy
12,709
+1,840
+17% +$127K 0.06% 374
2022
Q2
$753K Buy
10,869
+5,028
+86% +$373K 0.05% 375
2022
Q1
$449K Buy
5,841
+1,824
+45% +$131K 0.03% 494
2021
Q4
$308K Buy
4,017
+21
+0.5% +$1.54K 0.02% 523
2021
Q3
$295K Sell
3,996
-525
-12% -$39.4K 0.03% 482
2021
Q2
$302K Sell
4,521
-496
-10% -$33.2K 0.04% 438
2021
Q1
$373K Buy
5,017
+1,918
+62% +$146K 0.07% 333
2020
Q4
$226K Buy
+3,099
New +$219K 0.06% 363

Other funds holding HOLX

Ethic Inc's HOLX Position: Q2 2026 in Review

Ethic Inc sold out of Hologic (HOLX) in Q2 2026, closing a stake of 27,887 shares — an estimated $2.11M sold.

Ethic Inc first reported a position in HOLX in Q4 2020 and held it in 22 quarters. The position peaked at $2.11M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Ethic Inc reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Ethic Inc sold 27,887 Hologic shares in Q2 2026, an estimated $2.11M.
  • Ethic Inc first reported a position in Hologic in Q4 2020 and held it in 22 quarters.
  • Ethic Inc's Hologic position peaked at $2.11M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.